Medicare AdvantageAdministrativeLow impact
[California] Enhancing care for peri- and postmenopausal women: addressing recurrent UTIs with vaginal estrogen therapy
Anthem BCBS·CA · OB-GYN, Urology, Family Medicine +2 more·Provider Bulletin
Effective date
Aug 1, 2026
We identified it
Aug 2, 2026
Summary
Anthem Blue Cross (California Medicare Advantage) is promoting vaginal estrogen therapy as an evidence-based treatment option for peri- and postmenopausal women with recurrent UTIs, aligned with AUA guidelines. This is an educational provider bulletin encouraging providers to identify eligible patients and discuss this prevention strategy; no billing code changes, coverage restrictions, or prior authorization requirements are specified in this policy.
Action Required
No immediate billing or workflow changes required. This is an educational bulletin, not a coverage or billing policy change. Clinical staff may review AUA resources provided to understand vaginal estrogen therapy as a treatment option for eligible patients. No documentation requirements, prior authorization rules, or billing code changes are imposed by this policy.